bluebird bio, Inc. Insider Trading for September 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. for September 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 24.47 | 1,500 | 36,705 | 23,521 | |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 151.57 | 299 | 45,318 | 35,495 | 35.8 K to 35.5 K (-0.84 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 150.24 | 700 | 105,165 | 35,495 | 36.2 K to 35.5 K (-1.93 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 149.22 | 501 | 74,760 | 36,494 | 37 K to 36.5 K (-1.35 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 24.47 | 1,500 | 36,705 | 36,995 | 35.5 K to 37 K (+4.23 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 152.00 | 67 | 10,184 | 1,000 | 1.1 K to 1,000 (-6.28 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 151.22 | 501 | 75,762 | 1,067 | 1.6 K to 1.1 K (-31.95 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 150.06 | 432 | 64,825 | 1,568 | 2 K to 1.6 K (-21.60 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 32,700 | |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 15,800 | |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 166.25 | 100 | 16,625 | 31,871 | 32 K to 31.9 K (-0.31 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 165.28 | 200 | 33,055 | 31,971 | 32.2 K to 32 K (-0.62 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 164.03 | 213 | 34,939 | 32,171 | 32.4 K to 32.2 K (-0.66 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 162.90 | 510 | 83,081 | 32,384 | 32.9 K to 32.4 K (-1.55 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 161.83 | 777 | 125,742 | 32,894 | 33.7 K to 32.9 K (-2.31 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 75.60 | 700 | 52,920 | 33,671 | 33 K to 33.7 K (+2.12 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 32,971 | 32.4 K to 33 K (+1.85 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 7,000 | 38,503 | 36,951 | |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 168.25 | 1,425 | 239,751 | 24,905 | 26.3 K to 24.9 K (-5.41 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 167.30 | 1,070 | 179,010 | 26,330 | 27.4 K to 26.3 K (-3.91 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 166.50 | 2,083 | 346,821 | 27,400 | 29.5 K to 27.4 K (-7.07 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 165.53 | 2,422 | 400,911 | 29,483 | 31.9 K to 29.5 K (-7.59 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 7,000 | 38,503 | 31,905 | 24.9 K to 31.9 K (+28.11 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 24.47 | 7,250 | 177,408 | 25,021 | |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 4,007 | 22,040 | 0 | |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 2.09 | 8,743 | 18,241 | 0 | |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 176.03 | 978 | 172,155 | 35,495 | 36.5 K to 35.5 K (-2.68 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 175.37 | 19,022 | 3,335,793 | 36,473 | 55.5 K to 36.5 K (-34.28 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 24.47 | 7,250 | 177,408 | 55,495 | 48.2 K to 55.5 K (+15.03 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 4,007 | 22,040 | 48,245 | 44.2 K to 48.2 K (+9.06 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 2.09 | 8,743 | 18,241 | 44,238 | 35.5 K to 44.2 K (+24.63 %) |